2021
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
Han R, Yang H, Lu L, Lin L. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Scientific Reports 2021, 11: 8626. PMID: 33883691, PMCID: PMC8060393, DOI: 10.1038/s41598-021-88133-7.Peer-Reviewed Original ResearchConceptsLiver cancer developmentLiver cancerCancer developmentLiver cancer cell linesCD133 expression levelsAnti-proliferation effectQuantitative reverse transcription PCRCancer cell linesCancer deathTHLE-3THLE-3 cellsAlternative therapiesReverse transcription-PCREffective therapyFatal causeNC groupTherapeutic implicationsInvasion assaysTherapeutic useClinic practiceELISA kitHigher anti-proliferation effectColony formationTranscription-PCRAnticancer efficacy
2016
Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm
Prasad K, Sarkar A, Zafar MA, Shoker A, Moselhi HE, Tranquilli M, Ziganshin BA, Elefteriades JA. Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm. Aorta 2016, 04: 1-10. PMID: 27766267, PMCID: PMC5068493, DOI: 10.12945/j.aorta.2015.15.018.Peer-Reviewed Original ResearchAdvanced glycation end productsEndogenous secretory RAGEThoracic aortic aneurysmGlycation end productsMatrix metalloproteinasesSerum sRAGEAortic aneurysmSoluble receptorFormation of TAALevels of AGEsPathogenesis of TAALevels of sRAGEAGE-RAGE axisLevels of cytokinesProduction of cytokinesRelease of cytokinesAGEs/Control subjectsRisk factorsStudy populationSRAGEBlood samplesMMP-2CytokinesELISA kit
2014
Validity of a commercially available IgM ELISA test for diagnosing acute leptospirosis in high endemic districts of Sri Lanka
Agampodi S, Thevanesam V, Senaratne T. Validity of a commercially available IgM ELISA test for diagnosing acute leptospirosis in high endemic districts of Sri Lanka. Sri Lankan Journal Of Infectious Diseases 2014, 4: 83. DOI: 10.4038/sljid.v4i2.6952.Peer-Reviewed Original ResearchIgM ELISADiagnosis of leptospirosisConvalescent samplesImmunoglobulin M enzymeDays of illnessComparison groupCases of leptospirosisIgM ELISA kitResultsThe study sampleDepartment of MicrobiologyCare diagnostic testsFebrile patientsAcute leptospirosisFever patientsAcute samplesFaculty of MedicineHuman leptospirosisDay 14Disease confirmationELISA kitLeptospirosisPatientsDiagnostic testsImmunosorbent assayStudy sampleAnti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis
Lima I, Oliveira R, Cabral M, Atta A, Marchi S, Reis E, Reis M, Barbosa L, Santiago M. Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis. Rheumatology International 2014, 34: 1231-1234. PMID: 24719228, DOI: 10.1007/s00296-014-3009-z.Peer-Reviewed Original ResearchConceptsAnti-neutrophil cytoplasmic antibodiesAnti-PR3 antibodiesIndirect immunofluorescencePresence of ANCAPrevalence of ANCAInfectious diseasesComponents of neutrophilsGroup of patientsAnti-MPO antibodiesSera of patientsChest X-rayAnti-PR3Cytoplasmic antibodiesVasculitic syndromesTB patientsPulmonary tuberculosisAutoimmune disordersPresent studyClinical similaritiesSuch antibodiesPatientsELISA kitTuberculosisAntibodiesAutoantibodies
2013
Rubella seroprevalence among pregnant women in Burkina Faso
Tahita M, Hübschen J, Tarnagda Z, Ernest D, Charpentier E, Kremer J, Muller C, Ouedraogo J. Rubella seroprevalence among pregnant women in Burkina Faso. BMC Infectious Diseases 2013, 13: 164. PMID: 23556510, PMCID: PMC3623657, DOI: 10.1186/1471-2334-13-164.Peer-Reviewed Original ResearchConceptsOverall seropositivity ratePregnant womenRubella seroprevalenceSeropositivity rateNon-immune pregnant womenRubella-specific IgG antibodiesOverall immunity rateOlder age groupsRubella infectionEarly pregnancyAntibody titersRoutine immunizationCommercial ELISA kitIgG antibodiesImmunity rateRubella virusAge groupsELISA kitSerum samplesBurkina FasoWomenInternational unitsSeroprevalenceHigh percentageSerious consequences
2006
Frequency of antiphospholipid antibodies in patients with infectious diseases using three different ELISA methods
Santiago M, Martinelli R, Reis M, Reis E, Ko A, Fontes R, Silva M, Nascimento E, Espinola R, Harris N, Gharavi A, Pierangeli S. Frequency of antiphospholipid antibodies in patients with infectious diseases using three different ELISA methods. Jornal Brasileiro De Patologia E Medicina Laboratorial 2006, 42: 13-17. DOI: 10.1590/s1676-24442006000100004.Peer-Reviewed Original ResearchEnzyme-linked immunosorbent assayStandard enzyme-linked immunosorbent assayAntiphospholipid syndromeELISA kitInfectious diseasesAntiphospholipid antibodiesKala-azarACL ELISASera of patientsFrequency of positivityCases of leptospirosisCases of syphilisDetection of antibodiesAnticardiolipin antibodiesIgG aPLIgM aPLVisceral leishmaniasisELISA techniquePatientsHigh specificityELISA methodImmunosorbent assayDiseaseDiagnostic specificityGp I
2005
Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants
duPont N, Wang K, Wadhwa P, Culhane J, Nelson E. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants. Journal Of Reproductive Immunology 2005, 66: 175-191. PMID: 16029895, PMCID: PMC5738327, DOI: 10.1016/j.jri.2005.03.005.Peer-Reviewed Original ResearchConceptsMultiple immune mediatorsIL-1 betaCytokine expression patternsImmune system statusMajority of cytokinesAvailable ELISA kitsEnzyme-linked immunosorbentLuminex multiplex technologyImmune mediatorsIL-10Cytokine concentrationsIL-6IL-13IL-4IL-5TNF-alphaMAP kitIFN-gammaRespective pregnanciesImmune systemMultiple cytokinesELISA kitCytokinesExpression patternsMultiplex technology
1990
Nucleic acid hybridization in viral diagnosis
Landry M. Nucleic acid hybridization in viral diagnosis. Clinical Biochemistry 1990, 23: 267-277. PMID: 2225455, DOI: 10.1016/0009-9120(90)80053-l.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply